General MedicationsINJECTIONGeneric
NEPHROFLOW
IODOHIPPURATE SODIUM I-123
Standard Dose
1mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview NEPHROFLOW is listed in Drugs@FDA under application 018289 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient IODOHIPPURATE SODIUM I-123 Form and strength INJECTABLE;INJECTION - 1mCi/ML Sponsor GE HEALTHCARE Submission history Latest submission status date: 1984-12-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEPHROFLOW is listed in Drugs@FDA under application 018289 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IODOHIPPURATE SODIUM I-123 Form and strength INJECTABLE;INJECTION - 1mCi/ML Sponsor GE HEALTHCARE Submission history Latest submission status date: 1984-12-28 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.